Filters
The development of a comprehensive assessment methodology for the immune preparedness of members of the security and protective services responding to the COVID-19 pandemic (VI04000078)
in individuals infected with SARS-CoV-2 who possibly developed COVID-19 with different of the security and protective services responding to the COVID-19 pandemic. This tool would make it possible to iden...
Infectious Diseases
- 2021 - 2022 •
- 8 479 tis. Kč •
- 8 479 tis. Kč •
- MV
Řešení projektu: 1. 1. 2021 - 31. 12. 2022
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo vnitra
N antigen SARS-CoV-2 in the peripheral blood and risk factors of COVID-19 progression to severe clinical status (NU22-E-109)
of symptomatic COVID-19. In case of developed disease, we want to assess quantity of more severe forms of COVID-19. Together, we want to describe better reactivations of Herpes simplex virus (HSV) i patients with ...
Virology
- 2022 - 2023 •
- 1 873 tis. Kč •
- 1 873 tis. Kč •
- MZ
Řešení projektu: 1. 4. 2022 - 31. 12. 2023
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
Predicitve biomarkers of therapeutic response on COVID-19 therapy (NU22-A-105)
1) Analyze relationship between clinical course of COVID-19 in subjects compartment. 3) To study relationship between COVID-19 infection in hospitalized patients. Into this study will be enrolled 800 subjects recru...
Immunology
- 2022 - 2023 •
- 5 425 tis. Kč •
- 5 425 tis. Kč •
- MZ
Řešení projektu: 1. 4. 2022 - 31. 12. 2023
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
Clinical phenotype of persons vaccinated against Sars-CoV-2 hospitalized for COVID-19 disease as a basis for optimalization of national vaccination strategy and post-exposure prophylaxis (NU22-A-106)
Primary goal: Clinical and laboratory characteristics of patients with completed vaccination against SARS-CoV-2 admitted to the hospital in the standard ward and intensive care unit due to the severe course of COVID-19. Sec...
Critical care medicine and Emergency medicine
- 2022 - 2023 •
- 2 418 tis. Kč •
- 2 418 tis. Kč •
- MZ
Řešení projektu: 1. 4. 2022 - 31. 12. 2023
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
Prognostic factors affecting treatment outcomes and mortality in COVID-19 patients, new diagnostic methods, current and new terapeutic opportunities for COVID-19 (NU22-A-123)
corresponding to the severity of the course of COVID-19 disease that can be used in advanced on mortality and viral load in patients with severe course of COVID-19 disease with either University Hospital, as a hig...
Respiratory systems
- 2022 - 2023 •
- 4 123 tis. Kč •
- 4 123 tis. Kč •
- MZ
Řešení projektu: 1. 4. 2022 - 31. 12. 2023
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
Preventing complications in patients after COVID-19 disease - immune rehabilitation possibilities (NU22-E-152)
to the possibilities of how we can influence the immune response in connection with COVID-19 to the reduction of complications after COVID disease and the prevention of the development of so-called long COVID and ...
Immunology
- 2022 - 2023 •
- 4 020 tis. Kč •
- 4 020 tis. Kč •
- MZ
Řešení projektu: 1. 4. 2022 - 31. 12. 2023
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
Effect of COVID-19 pandemic on surgical care for patients with solid tumors of gastrointestinal tract in the Czech Republic (NU22-C-113)
The aim of the present study is to investigate the influence of COVID-19, deviations from standard multidisciplinary treatment management, the impact of COVID-19 gastrointestinal malignant tumours during COVID<...
Surgery
- 2022 - 2023 •
- 4 400 tis. Kč •
- 4 400 tis. Kč •
- MZ
Řešení projektu: 1. 4. 2022 - 31. 12. 2023
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
Management of antibiotic treatment in patients with critical Covid-19 (NU22-B-112)
Re-evaluation of the role of antibiotic treatment in patients with Covid-19 with critical Covid-19. 2. To determine the spectrum of bacterial pathogens, to analyze the influence of antibiotic selection pressure on ...
Critical care medicine and Emergency medicine
- 2022 - 2023 •
- 4 695 tis. Kč •
- 4 695 tis. Kč •
- MZ
Řešení projektu: 1. 4. 2022 - 31. 12. 2023
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
Therapeutic recombinant antigens and monoclonal antibodies - Theramab (FX03030181)
The project focuses on immunotherapy of infectious diseases Covid-19 and AIDS by preventive recombinant vaccines and therapeutic monoclonal antibodies. The goal antigens for Covid-19 and AIDS vaccines and the simu...
Industrial biotechnology
- 2021 - 2024 •
- 50 861 tis. Kč •
- 24 419 tis. Kč •
- MPO
Řešení projektu: 1. 6. 2021 - 31. 8. 2024
Uznané náklady
Podpora ze státního rozpočtu (48%)
Poskytovatel: Ministerstvo průmyslu a obchodu
MRI MORPHOMETRIC AND PROTEOMIC MARKERS OBTAINED FROM BRAIN-DERIVED EXOSOMES BEFORE AND AFTER SARS-COV-2 INFECTION (NU22-D-136)
be of substantial benefit to the unraveling of the principles of SARS-CoV-2 neurotrophic effect profiling as the multimodal substrate of the long-COVID syndrome.......
Psychiatry
- 2022 - 2023 •
- 6 530 tis. Kč •
- 6 530 tis. Kč •
- MZ
Řešení projektu: 1. 4. 2022 - 31. 12. 2023
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
- 1 - 10 out of 330